The Nobel Lie
When I started my PhD, I wanted to win the Nobel Prize. It feels a little ridiculous to write that now, but I don't think it was ridiculous then. I was young, ambitious, and enamored with science. The Nobel Prize represented the highest achievement in scientific discovery. Make an important discovery, change how we understand biology or disease, and eventually the world recognizes it. What I did not understand was everything that happens between discovery and recognition.
My first real lesson came in 2011. That year, the Nobel Prize in Physiology or Medicine recognized Bruce Beutler and Jules Hoffmann for discoveries in innate immunity and Ralph Steinman for dendritic cells. As someone fascinated by innate immunity, I knew another version of that history. Charles Janeway had proposed the framework of pattern recognition, and his protégé, Ruslan Medzhitov, helped establish its molecular basis. Janeway had died in 2003 and was ineligible. Medzhitov was very much alive, yet did not receive it. The reaction was revealing. James Allison and colleagues published a correspondence in Nature arguing that their seminal contributions deserved recognition. In another unusual twist, Steinman had died three days before the announcement, unbeknownst to the Nobel Committee, which allowed the award to stand.
None of this diminished the extraordinary science recognized that year. But it was the first time I understood that even something as definitive as a Nobel Prize was still an interpretation of history. The science could be extraordinary, and the allocation of credit could still be complicated. I suppose it should not have surprised me. There are only so many Nobel Prizes, grants, prestigious publications, faculty positions, and square feet of laboratory space. Scarcity inevitably creates politics, and science is practiced by human beings.
Perhaps nowhere was that more obvious than CRISPR. As genome editing transformed biology, another contest emerged over who would own the history of its discovery. In 2016, Eric Lander, then director of the Broad Institute, published "The Heroes of CRISPR" in Cell amid a consequential patent dispute. Critics argued that his account diminished Jennifer Doudna's and Emmanuelle Charpentier's contributions while elevating Broad scientist Feng Zhang. The experiments had been performed and the papers published, yet the story of who deserved credit was still being contested in a prestigious journal. Doudna and Charpentier ultimately received the 2020 Nobel Prize in Chemistry. Zhang did not. Scientists do not simply make discoveries. They also compete to define who made them and whose contributions history will remember.
And that brings us to 2026. This year's Nobel Prize in Physiology or Medicine recognized Karl Deisseroth, Peter Hegemann, and Georg Nagel for discoveries underlying optogenetics, which transformed neuroscience by allowing researchers to control neuronal activity using light. Yet familiar questions emerged. What about Edward Boyden, first author of the seminal 2005 Nature Neuroscience paper, or Feng Zhang, another central contributor? What about Gero Miesenböck, who demonstrated earlier approaches to optical control? And what about Zhuo-Hua Pan?
Pan, a Wayne State University researcher, demonstrated channelrhodopsin-mediated light responses in retinal neurons in early 2004. His manuscript was redirected from Nature to Nature Neuroscience, where it was rejected, followed by another rejection at The Journal of Neuroscience. Meanwhile, the Stanford group's paper appeared in Nature Neuroscience in August 2005. Pan's work was eventually published in Neuron in April 2006. Two groups pursuing related approaches, making important discoveries, but encountering very different publication timelines. How much of what we call a breakthrough depends on the discovery itself, and how much depends on how successfully it is framed, published, and promoted?
Deisseroth has become an exceptionally effective storyteller of his scientific journey. In recounting the early optogenetics experiments, he has presented the laboratory notebook documenting how a microbial light-sensitive protein could function in mammalian neurons. There is something theatrical about it. Here are the notes. Here is the experiment. Here is the moment that changed neuroscience. As scientists, we love the idea that transformative discoveries begin with a few handwritten notes and an experiment that unexpectedly works. But a laboratory notebook documents an experiment, not the full history of a discovery. The familiar origin story makes something extraordinarily complicated seem simple: one scientist, one idea, one experiment, one breakthrough. The reality is rarely so tidy.
I have recognized these same dynamics closer to home. Universities like to imagine themselves as meritocracies. Yet I have seen laboratory space sit underused while others struggle for room, resources treated as entitlements, and opportunities distributed according to relationships and institutional hierarchy. I have benefited from this system at times and been frustrated by it at others. Eventually, you realize that being good at science and succeeding in science are overlapping, but not identical, skill sets. You need good ideas, rigor, and persistence, but also advocates, institutional support, and visibility. I used to think acknowledging this cheapened science. Now I think pretending otherwise is more dangerous.
Because the problem is not simply who receives prizes. Recognition helps determine which scientific ideas receive attention, resources, and legitimacy. Celebrated discoveries can harden into scientific dogma. Certain mechanisms dominate grant applications, influential investigators become authorities, and competing ideas struggle for attention even when the evidence warrants consideration. These decisions shape which hypotheses get funded, which manuscripts get published, and which technologies advance. In biomedical research, they can potentially delay promising therapeutic approaches.
We describe ourselves as seekers of truth, and at its best, science is exactly that. But the institutions surrounding the scientific method remain profoundly human. Every October, we compress decades of scientific progress into a handful of names announced from Stockholm. It makes for a compelling story, but an incomplete one.
The lie I believed as a young scientist was that scientific merit and scientific success were essentially the same thing. That important work would inevitably rise to the top, and recognition would naturally follow. I no longer believe that. Hard work only gets you so far. Politics matters. Relationships matter. Institutional power matters. Narrative matters. Luck matters. And sometimes consequential discoveries are overlooked because they do not fit the story we have already decided to tell.
The truth does not require a Nobel Prize. But our willingness to recognize it may depend far more on politics than we care to admit.
